Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.
Report ID | 147717 |
Drug Identification Number | 02173360 |
Brand name | TEVA-SALBUTAMOL STERINEBS P.F. |
Common or Proper name | SALBUTAMOL 2MG/ML NEBS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SALBUTAMOL |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 2.5ml |
ATC code | R03AC |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-10-20 |
Estimated end date | 2022-10-20 |
Actual end date | 2022-10-17 |
Shortage status | Resolved |
Updated date | 2022-10-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.